Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Nov 21;11(11):e0166730. doi: 10.1371/journal.pone.0166730

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Mondal et al

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Fig 2 — (A) Graphical presentation of percentage of isolates exhibiting resistance to respective antibiotics used in this study. To determine the percentage of drug resistance, disc diffusion assay was performed using AZM: azithromycin, CAZ: ceftazidime, CHL: chloramphenicol, CIP: ciprofloxacin, CST: colistin, CTR: ceftriaxone, DOX: doxycycline, ENX: norfloxacin, ERY: erythromycin, ETP: ertapenem, FEP: cefepime, GEN: gentamicin, IMP: imipenem, KAN: kanamycin, LZD: linezolid, MIN: minocycline, NAL: nalidixic acid, NOR: norfloxacin, RIF: rifampicin, SPT: spectinomycin, STR: streptomycin, TET: tetracycline, TGC: tigecycline, TMP: trimethoprim, TOB: tobramycin, and analyzed as per standard CLSI standards. (B) The K. pneumoniae strains showed resistance toward multiple antibiotics, we grouped the pool of isolates as per the number of antibiotics they were showing resistance to. Here percentages of isolates belonging to different groups with different number of antibiotic resistance are shown where the respective number of antibiotics is mentioned within bracket with each group.